Office of Research

Martin Delaney Collaboratories for HIV Cure Research (UM1 Clinical Trial Not Allowed)

Limited Submissions

UIPDATE: We're recalling this announcement as the UW already has an appliocant.

The purpose of this Funding Opportunity Announcement (FOA) is to address the problem of HIV persistence in people living with HIV treated with suppressive antiretroviral drug regimens. This FOA will support coordinated basic, clinical, and applied research focused on developing strategies to achieve an HIV cure, defined as either sustained viral remission or eradication of HIV infection. While some aspect of clinical research is required, unlike the previous iteration of this RFA, clinical trials will no longer be supported. The application must include at least one private sector entity to facilitate rapid translation of basic discovery research into therapeutic development and testing. Collaboratory research should be milestone-based and should be focused on specific innovative approaches to characterize and quantify persistent HIV-1 reservoirs and/or understand and predict post-treatment control of viral rebound, identify and test therapeutic strategies to control viral rebound after discontinuation of antiretroviral therapy, and identify and test strategies to eradicate or permanently inactivate rebound-competent HIV.

Application Instructions

Please submit:

  1. a one-page letter of intent with a description of proposed aims and approach
  2. CV (not NIH format)  of the PI

 

to research@uw.edu by 5:00 PM Thursday September 24, 2020. Proposals are due to the 12/7/20, so you will need to have your materials in to the Office of Sponsored Programs by 11/25/20 for processing, if given the go ahead by the Proposal Review Committee.

Opportunity Details

Program web page

Program Announcement No.

RFA-AI-20-035

Deadlines
09/24/2020 UW Internal Deadline Closed
11/25/2020 OSP Deadline
12/07/2020 Sponsor Deadline
Sponsor

National Institutes of Health (NIH)

Funding amount

$16,777,215

Maximum Number of Applications

1

Eligible groups
  • All campus

Inquiries and Contact Information

Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.

For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.